Immunis has reported interim Phase 2 clinical data showing improvements in physical function among...
Author - Abby Davey
Wave Life Sciences 2026 strategic priorities accelerate WVE-007...
Wave Life Sciences 2026 strategic priorities were outlined by the company at the 44th Annual J.P...
Novartis ianalumab receives FDA Breakthrough Therapy designation...
Novartis has received US Food and Drug Administration Breakthrough Therapy designation for...
Agentic AI gap highlighted across life sciences and pharma...
Life sciences and pharmaceutical organisations report a growing gap between their ambitions for...
Jasper Therapeutics reports positive briquilimab data in chronic...
Jasper Therapeutics has reported updated clinical data showing disease control in patients treated...
Beacon Therapeutics Series C financing raises over $75 million
Beacon Therapeutics has secured more than $75 million in Series C financing to advance the...
Waterborne disease poses a growing global threat as water...
Waterborne disease is emerging as a significant and growing public health threat across both...
Breast cancer remains the world’s most-studied disease area in...
Phesi has published its latest annual analysis of global clinical development activity, based on...
Bayer receives Breakthrough Therapy Designation for sevabertinib...
Bayer has received Breakthrough Therapy Designation in the United States and China for sevabertinib...
Alnylam to invest $250 million in enzymatic ligation platform to...
Alnylam Pharmaceuticals has announced a $250 million investment to expand its US manufacturing...